ID   HOB1/ADR2.0
AC   CVCL_J392
DR   Wikidata; Q54890098
RX   PubMed=1360209;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J391 ! HOB1
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
RX   PubMed=1360209; DOI=10.1016/0006-291X(92)91530-4;
RA   Lee W.-P., Lee C.-L., Kao M.-C.;
RT   "Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that
RT   does not play the major role in the development of drug resistance to
RT   adriamycin.";
RL   Biochem. Biophys. Res. Commun. 189:92-100(1992).
//